Psychosocial interventions for depression and anxiety in Parkinson's disease
- PMID: 22689704
- DOI: 10.1177/0891988712445096
Psychosocial interventions for depression and anxiety in Parkinson's disease
Abstract
Background: Depression has been estimated to affect 1 in 3 individuals with Parkinson's disease (PD) and can lead to worse health outcomes and decreased quality of life. Anxiety further complicates PD outcomes. Pharmacologic treatments of depression and anxiety can have negative side effects in patients with PD, including exacerbation of PD symptoms. There is a critical need for alternative treatment approaches that address depression and anxiety among patients with PD. Psychosocial or behavioral approaches are known to be effective for depression generally, but only a handful of studies have examined the role of psychosocial treatments of patients with depression in PD.
Objective: The aim of this article was to review published psychosocial treatment studies of depression and anxiety in patients with PD.
Methods: The PubMed database was searched for articles published in English before April 2011 using the terms Parkinson's disease, depression, anxiety, psychotherapy, cognitive therapy, behavioral treatment, behavioral therapy, nonpharmacologic treatment, psychoeducation, education, psychosocial treatment, and stress management. Articles included were prospective clinical trials utilizing specific depression or anxiety assessments as primary or secondary outcomes in patients with PD.
Results: Nine reports derived from 8 separate studies fit the inclusion criteria and were included in this review. All studies were published between 1997 and 2011, and all but 3 had small sample sizes (<40 patients). Interventions included cognitive behavioral therapy (CBT), psychodrama, education, and behavior therapy as well as multidisciplinary rehabilitation. Cognitive behavioral therapy was the most studied and was shown to decrease depressive and anxiety symptoms in patients with PD. Other individual and group therapies may improve depression and anxiety in patients with PD, but the general paucity of studies and study methods limit the interpretation of these results.
Conclusions: There have been few studies on psychosocial treatments that specifically assess change in depression and anxiety among patients with PD. While results for CBT and other modes of therapy are promising for acute management of depression and anxiety, longer term effects after treatment have been variable. There is a need for additional studies on psychosocial interventions in people with PD.
Similar articles
-
Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review.J Parkinsons Dis. 2012;2(2):135-51. doi: 10.3233/JPD-2012-12080. J Parkinsons Dis. 2012. PMID: 23939438 Review.
-
Is cognitive-behavioral therapy more effective than other therapies? A meta-analytic review.Clin Psychol Rev. 2010 Aug;30(6):710-20. doi: 10.1016/j.cpr.2010.05.003. Epub 2010 May 25. Clin Psychol Rev. 2010. PMID: 20547435
-
Psychiatric care in Parkinson's disease.J Psychiatr Pract. 2013 Mar;19(2):118-41. doi: 10.1097/01.pra.0000428558.94329.6d. J Psychiatr Pract. 2013. PMID: 23507813 Review.
-
Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson's Disease.J Parkinsons Dis. 2015;5(3):443-51. doi: 10.3233/JPD-150542. J Parkinsons Dis. 2015. PMID: 26406124 Free PMC article. Review.
-
Group cognitive-behavioral therapy for patients with epilepsy and comorbid depression and anxiety.Epilepsy Behav. 2011 Jan;20(1):83-8. doi: 10.1016/j.yebeh.2010.10.028. Epub 2010 Dec 4. Epilepsy Behav. 2011. PMID: 21131237
Cited by
-
Effects of music and music therapy on mood in neurological patients.World J Psychiatry. 2015 Mar 22;5(1):68-78. doi: 10.5498/wjp.v5.i1.68. World J Psychiatry. 2015. PMID: 25815256 Free PMC article. Review.
-
Responsiveness of the short-form health survey and the Parkinson's disease questionnaire in patients with Parkinson's disease.Health Qual Life Outcomes. 2017 Apr 18;15(1):75. doi: 10.1186/s12955-017-0642-8. Health Qual Life Outcomes. 2017. PMID: 28420397 Free PMC article.
-
Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis.PLoS One. 2013 Oct 2;8(10):e76651. doi: 10.1371/journal.pone.0076651. eCollection 2013. PLoS One. 2013. PMID: 24098546 Free PMC article.
-
The Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson's Disease.Front Hum Neurosci. 2016 Apr 22;10:161. doi: 10.3389/fnhum.2016.00161. eCollection 2016. Front Hum Neurosci. 2016. PMID: 27148016 Free PMC article. Review.
-
Cost-Effectiveness Analyses of Non-Pharmacological and Non-Surgical Interventions in Idiopathic Parkinson's Disease: A Systematic Review.J Parkinsons Dis. 2024;14(s1):S241-S252. doi: 10.3233/JPD-230213. J Parkinsons Dis. 2024. PMID: 38339939 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous